Featured Research

from universities, journals, and other organizations

Antidepressants Safe For Children And Adolescents, Analysis Suggests

Date:
April 18, 2007
Source:
University of Pittsburgh Schools of the Health Sciences
Summary:
Antidepressants are safe and effective for treating anxiety, OCD and major depressive disorder in children and adolescents, according to a meta-analysis of 27 major studies. The findings call into question the controversial "black box" warnings placed on the drugs by the FDA, which say antidepressant medications pose a small but significantly increased risk of suicidal thoughts and behavior for children and adolescents.

Antidepressants are safe and effective for treating anxiety, obsessive compulsive disorder (OCD) and major depressive disorder in children and adolescents, according to a meta-analysis of 27 major studies. The findings, published by University of Pittsburgh School of Medicine researchers in this week's Journal of the American Medical Association (JAMA), call into question the controversial "black box" warnings placed on the drugs by the Food and Drug Administration, which say that antidepressant medications pose a small but significantly increased risk of suicidal thoughts and behavior for children and adolescents.

"As clinicians, our first concern is for the health and safety of our patients. When the FDA placed the 'black box' warning on antidepressants, it raised a great deal of concern about how we were to treat our young patients who we thought could possibly benefit from antidepressant therapy. Most clinicians, patients and their families found themselves questioning whether or not they should be using treatments out of fear of the risks," said David A. Brent, M.D., professor of psychiatry, University of Pittsburgh School of Medicine. "By combining data from most of the significant studies of antidepressant use in adolescents and children, we've been able to examine a balance of benefits and risks of these medications.

"Antidepressants are safe and effective for treating disorders like anxiety, OCD and depression in children and adolescents," Dr. Brent continued. "While there is a small, increased risk of suicidal thoughts in those who use antidepressants, it would be much, much riskier to not treat these children and adolescents dealing with these disorders."

For this study, the University of Pittsburgh researchers extracted data on study characteristics, efficacy outcomes and emergent suicidal events from 27 trials of second-generation antidepressants used to treat pediatric major depressive disorder, OCD and anxiety in children and adolescents under the age of 19. Fifteen trials were of major depressive disorder and included a total of 3,430 participants; six trials were of OCD, with 718 participants; and six trials were of anxiety, with 1,162 participants. The drugs used were the selective serotonin reuptake inhibitors (SSRIs) nefazodone, venlafaxine and mirtazapine; all of the studies were randomized and placebo-controlled.

Researchers found that one in 100 participants in the studies included in the meta-analysis had new-onset suicidal ideation, or suicidal thoughts, while on medication. Even fewer acted on these thoughts, and there were no completed suicides.

The results showed that antidepressants were most effective in treating anxiety, moderately effective for OCD and modestly effective for depression. The number needed to treat (NNT) -- a statistical term meaning the number of patients a clinician would need to treat to prevent an adverse outcome in one -- was 10 for major depressive disorder, six for OCD and four for anxiety. The number needed to harm (NNH) -- the number of patients who would need to be treated for one to be harmed -- was 112 for major depressive disorder, 200 for OCD and 143 for anxiety. These numbers indicate that the increased risk, while not unimportant, is not enough to outweigh the benefits of taking the medications.

"While I support the FDA's role in monitoring the safety of medications, in this case, the FDA should reconsider the black box warning on these medications," said Dr. Brent. "Our study supports the cautious and well-monitored use of antidepressant medications as a first-line treatment for anxiety, OCD and depression."

The study was funded by the National Institute of Mental Health, one of the National Institutes of Health.

Co-authors of the study include: Jeffrey A. Bridge, Ph.D., of the Ohio State University and formerly of the University of Pittsburgh; Satish Iyengar, Ph.D., Cheryl B. Salary, M.D., and Boris Birmaher, M.D., of the University of Pittsburgh School of Medicine's Department of Psychiatry and Western Psychiatric Institute and Clinic of UPMC; Harold A. Pincus, M.D., of the University of Pittsburgh and Columbia University; Remy P. Barbe, M.D., of the University of Pittsburgh and University Hospital of Geneva; and Lulu Ren, Ph.D., currently with AmGen Inc. in San Francisco.


Story Source:

The above story is based on materials provided by University of Pittsburgh Schools of the Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

University of Pittsburgh Schools of the Health Sciences. "Antidepressants Safe For Children And Adolescents, Analysis Suggests." ScienceDaily. ScienceDaily, 18 April 2007. <www.sciencedaily.com/releases/2007/04/070417182943.htm>.
University of Pittsburgh Schools of the Health Sciences. (2007, April 18). Antidepressants Safe For Children And Adolescents, Analysis Suggests. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2007/04/070417182943.htm
University of Pittsburgh Schools of the Health Sciences. "Antidepressants Safe For Children And Adolescents, Analysis Suggests." ScienceDaily. www.sciencedaily.com/releases/2007/04/070417182943.htm (accessed July 29, 2014).

Share This




More Mind & Brain News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com
University Quiz Implies Atheists Are Smarter Than Christians

University Quiz Implies Atheists Are Smarter Than Christians

Newsy (July 25, 2014) An online quiz from a required course at Ohio State is making waves for suggesting atheists are inherently smarter than Christians. Video provided by Newsy
Powered by NewsLook.com
Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins